|
⚲
|
| Keyboard |
| Kay Mark A
✚
|
|
|---|---|
| CIK # | 0001752537 |
| EDGAR Form | CIK | 2011 - 2026 |
|---|---|---|
| 3 | [0001752537] | |
| 4 | [0001752537] |
| Form 3/4/5 Subject | 2011 - 2026 |
|---|---|
| LogicBio Therapeutics Inc | |
| Kay Mark A |
| Insider Transaction (Form 3/4/5) | Date | Action | Shares | Price | Value ($) |
|---|---|---|---|---|---|
|
LogicBio Therapeutics Inc LOGC
Stock Option (right to buy) · derivative
|
2022-11-16 | Disposed to issuer | 140,615 | ||
|
LogicBio Therapeutics Inc LOGC
Stock Option (right to buy) · derivative
|
2022-11-16 | Disposed to issuer | 13,089 | ||
|
LogicBio Therapeutics Inc LOGC
Common Stock
|
2022-11-16 | Disposed to issuer | 784,557 | ||
|
LogicBio Therapeutics Inc LOGC
Stock Option (right to buy) · derivative
|
2022-11-16 | Disposed to issuer | 12,500 | ||
|
LogicBio Therapeutics Inc LOGC
Stock Option (right to buy) · derivative
|
2022-06-17 | Grant | 12,500 | $0.00 | |
|
LogicBio Therapeutics Inc LOGC
Stock Option (right to buy) · derivative
|
2021-06-18 | Grant | 5,000 | $0.00 | |
|
LogicBio Therapeutics Inc LOGC
Stock Option (right to buy) · derivative
|
2021-06-11 | Grant | 12,500 | $0.00 | |
|
LogicBio Therapeutics Inc LOGC
Common Stock
|
2021-01-01 | Option exercise | 2,199 | ||
|
LogicBio Therapeutics Inc LOGC
Restricted Stock Units · derivative
|
2021-01-01 | Option exercise | 2,199 | $0.00 | |
|
LogicBio Therapeutics Inc LOGC
Stock Option (right to buy) · derivative
|
2020-06-19 | Grant | 10,000 | $0.00 | |
|
LogicBio Therapeutics Inc LOGC
Restricted Stock Units · derivative
|
2020-06-19 | Grant | 2,199 | $0.00 | |
|
LogicBio Therapeutics Inc LOGC
Stock Option (right to buy) · derivative
|
2019-12-19 | Grant | 10,869 | $0.00 | |
|
LogicBio Therapeutics Inc LOGC
Stock Option (right to buy) · derivative
|
2018-10-18 | Grant | 24,102 | $0.00 |